Results (3746)

PRAC carried out its broad range of responsibilities for managing the risks associated with medicine use
Yearly updates to virus strains ensure vaccine effectiveness

Designation facilitates data sharing, promotes transparency and trust in clinical research

Proposal aims to encourage development and improve patient access

Data comes from EU27 plus Iceland and Norway
Benefits continue to outweigh risks, with new risk minimisation measures and more information to be provided about long-term effect on the heart

Five new medicines recommended for approval; another seven medicines recommended for extension of their therapeutic indications

Manufacturers can request advice on their medical device clinical development programme

Artificial intelligence tool reliably identifies disease severity and reduces variability

Seizing opportunities in a changing medicines landscape